Safety and efficacy of pembrolizumab plus lenvatinib versus pembrolizumab and lenvatinib monotherapies in cancers: A systematic review
Dun‐Chang Mo, Peng‐Hui Luo, Shang‐Xiao Huang, Han‐Lei Wang, Jianfeng Huang
Topics & Concepts
LenvatinibPembrolizumabMedicineInternal medicineOncologyRenal cell carcinomaAdverse effectCancerSorafenibHepatocellular carcinomaImmunotherapyCancer Immunotherapy and BiomarkersCancer Research and TreatmentsPeptidase Inhibition and Analysis